National and Kapodistrian University of Athens
Ανοσοϊστοχημική μελέτη των βιολογικών μορίων TGF-β1, BMP-2, HGF-a και οστεοποντίνης σε κακοήθεις όγκους σιαλογόνων αδένων
Abstract
dc:descriptionMalignant growth is essentially characterized by an uncontrolled tissue remodeling process in which normal tissue is substituted by cancer tissue. Interaction between tumor and stromal cells plays a major role in cancer progression. Tumor cells can reside in the stroma and modify it, they can alter the connective tissue, modulate the metabolism of stroma cells thus creating a convenient environment. In addition the tumor stroma contains a rich cellular population, which includes fibroblasts, endothelail cells, macrophages and other inflammatory cells. Malignant cells interact with the microenviroment through the release of soluble factors p.ex. integrins, TGF, IL6,IL8, HGF. Several studies have demonstrated high concentrations of growth factors in malignant tumors of the brest, stomach, endometrium, melanoma. Only 3-6% of head and neck tumors occur in the salivary glands. Salivary gland neoplasms show a striking range of morphological and histological diversity between different tumor types and sometimes within an individual tumor mass. The histological classification of salivary gland tumors is under the consideration of the world health organization. Prognosis strongly correlates with the clinical stage (tumor size, local invasion, metastasis regional or distant) and histopathological grade, emphasizing the importance of early diagnosis. PURPOSE. The purpose of this study was the immunohistochemical evaluation of TGF-β1, BMP-2, HGFa, OST expression in salivary gland malignant neoplasms and the correlation with clinical and histopathological parameters (age, sex, TNM system). MATERIAL AND METHODS. The material consisted of 54 specimens of malignant salivary gland tumors from the Oral and Maxilofaciall Surgery Department of “Evangelismos” General Hospital in Athens during the years 1996-2008 The specimens were fixed in 10% formalin for more than 24 hours. The antibodies used for immunohistichemical evaluation were: 1. TGF-β1 (sc-52893, Santa Cruz Biotechnology, Inc) mouse monoclonal antibody in working dilution 1: 50. Positive controls: thyroid gland tissue 2. HGFa (sc-7949, Santa Cruz Biotechnology, Inc) rabbit polyclonal antibody working dilution 1:150. Positive control gall bladder tissue 3. Osteopontin (E-3284, Spring Bioscience) rabbit polyclonal antibody in working dilution 1: 100. Positive control: breast cancer tissue 4. BMP-2/4 (BAF-355,R&DSystems) goat monoclonal antibody in working dilution 1: 150. Positive control: thyroid glad tissue RESULTS. The results of this study were the following: Of the 54 cases, 29 (53.7%) were males and 25 (46.3%) females with mean age 53.4 years. The tumors were classified as follows: 19 adenoid cystic carcinomas. 7 (13.0%) of them were high grade carcinomas and 12 (22.2%) intermediate grade, 13 mucoepidermoid carcinomas. 2 (3.7%) were high grade, 3 (5.6%) intermediate grade and 8 (14.8%) low grade mucoepidermoid carcinomas 5 (9.3%) polymorphous low grade adenocarcinomas, 2 (3.7%) adenocarcinomas not otherwise specified, 1 (1.9%) salivary duct carcinoma, 3 (5.6%) mucinous adenocarcinomas, 1 (1.9%) carcinoma ex pleomorphic adenoma, 4 (7.4%) basal cell adenocarcinomas, 6 (11.1%) myoepithelial carcinomas. The tumors (stage I- IVA) were located intraoraly and extraoraly as well. The expression of TGF-β1 in malignant salivary gland neoplasms was weak and focal. Weak positive immunohistochemical stain (+) was observed in 33.3%. Mesenchimal cells expressed a weak immunohistichemical stain (+) in 37.0% of the cases. Statistical analysis also revealed correlation between the expression of TGF-β1 in stroma cells and the stage of the tumors. Intense expression of TGF-b1 was observed in high stage neoplasms. Positive immunohistochemical stain of BMP-2 (++) was observed in 3.7% of the malignant salivary gland neoplasms and weak expression (+) in 53.7%. The only significant correlation observed with the HGF-a expression. Osteopontin expression was also focal and didn’t extend in all tumor area. Intense positive immunohistochemical stain (+++) was observed in 9.25% of salivary gland tumors and (++) in 14.8%. The study revealed correlation between osteopontin expression and tumor location and age of the patients. Last HGF-a expression was moderate and extended in all the tumor mass. The stain was located in the cytoplasm of epithelial cancer cells. Positive immunohistochemical stain (++) was observed in 14.81% of the malignant salivary gland neoplasms and weak expression (+) in 68.51%. Statistical analysis revealed significant correlation was between HGFa expression and gender of patients, tumor stage and BMP-2 expression. CONCLUSIONS. The results of this study revealed the expression of the biological molecules (TGF-β1, ΒΜΡ-2, OST, HGF-a) in salivary gland malignant neoplasms. The statistical analysis of the results demonstrated a significant correlation between the expression of these factors and clinical and pathological parameters such as age and gender of patients, tumor location and tumor stage. In conclusion these results have provided a useful data for further investigation on the important role of these biomarkers in tumor progression.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Φωτόπουλος, Διονύσιος
Subjects
dc:subject × 21- Ανοσοϊστοχημική μελέτη
- Αυξητικός παράγοντας μετασχηματισμού-β1
- Μορφογενετική πρωτεΐνη οστού-2
- Ηπατοκυτταρικός αυξητικός παράγοντας-α
- Οστεοποντίνη ( OPN)
- Όγκοι σιαλογόνων αδένων
- Κακοήθεις όγκοι σιαλογόνων αδένων
- Immunohistochemical evaluation
- Transforming growth factor β1
- Bone morphogenetic protein-2
- TGF-b1
- BMP-2
- HGF-A
- Hepatocyte growth factor-a
- Osteopontin (OPN)
- Salivary gland tumours
- Malignant salivary gland tumours
- Ιατρική και Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27222